The growing complexity of HIF-1α’s role in tumorigenesis: DNA repair and beyond

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Oncogene

• Publication date

  2013-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/onc.2012.510PMID 23160373
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Biology of Cancer

  2015cited by this paper
• Angiogenesis and Metastasis

  2015cited by this paper
• The DNA damage response and cancer therapy

  2012cited by this paper
• Chromatin as an oxygen sensor and active player in the hypoxia response

  2012cited by this paper
• Intratumor heterogeneity and branched evolution revealed by multiregion sequencing.

  2012cited by this paper
• Deregulated MYC expression induces dependence upon AMPK-related kinase 5

  2012cited by this paper
• Checkpoint control and cancer

  2012cited by this paper
• Tubular Injury in a Rat Model of Type 2 Diabetes Is Prevented by Metformin

  2011cited by this paper
• Oxygen sensing, homeostasis, and disease.

  2011cited by this paper
• Reciprocal influence of the p53 and the hypoxic pathways

  2011cited by this paper
• A decade of exploring the cancer epigenome — biological and translational implications

  2011cited by this paper
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression

  2011cited by this paper
• Physiological and biochemical aspects of hydroxylations and demethylations catalyzed by human 2-oxoglutarate oxygenases.

  2011cited by this paper
• Targeting cancer metabolism: a therapeutic window opens

  2011cited by this paper
• More than just a focus: The chromatin response to DNA damage and its role in genome integrity maintenance

  2011cited by this paper
• Metabolic Profiling of Hypoxic Cells Revealed a Catabolic Signature Required for Cell Survival

  2011cited by this paper
• Poly(ADP‐Ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic

  2011cited by this paper
• Hypoxia and energetic tumour metabolism.

  2011cited by this paper
• mechanisms of disease Oxygen Sensing , Homeostasis , and Disease

  2011cited by this paper
• Hypoxia-mediated drug resistance: novel insights on the functional interaction of HIFs and cell death pathways.

  2011cited by this paper
• Effects of HIF-1α and HIF2α on Growth and Metabolism of Clear-Cell Renal Cell Carcinoma 786-0 Xenografts

  2010cited by this paper
• HIF-1 antagonizes p53-mediated apoptosis through a secreted neuronal tyrosinase

  2010cited by this paper
• BRCA1 and its toolbox for the maintenance of genome integrity

  2010cited by this paper
• Rethinking the Warburg effect with Myc micromanaging glutamine metabolism.

  2010cited by this paper
• Role of hypoxia-inducible transcription factor 1α for progression and chemosensitivity of murine hepatocellular carcinoma

  2010cited by this paper
• Hypoxia-Inducible Factor 1α Determines Gastric Cancer Chemosensitivity via Modulation of p53 and NF-κB

  2010cited by this paper
• Roles of Coactivators in Hypoxic Induction of the Erythropoietin Gene

  2010cited by this paper
• Biologically Targeted Cancer Therapy and Marginal Benefits: Are We Making Too Much of Too Little or Are We Achieving Too Little by Giving Too Much?

  2010cited by this paper
• Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics

  2010cited by this paper
• Pericytes and vessel maturation during tumor angiogenesis and metastasis

  2010cited by this paper
• The DNA damage response: making it safe to play with knives.

  2010cited by this paper
• Telomeres and telomerase in cancer.

  2010cited by this paper
• HIF-1: upstream and downstream of cancer metabolism.

  2010cited by this paper
• RNAi screen for telomerase reverse transcriptase transcriptional regulators identifies HIF1α as critical for telomerase function in murine embryonic stem cells

  2010cited by this paper
• Hypoxia and metastasis in breast cancer.

  2010cited by this paper
• mTORC1 signaling under hypoxic conditions is controlled by ATM-dependent phosphorylation of HIF-1α.

  2010cited by this paper
• Hypoxia prevents etoposide-induced DNA damage in cancer cells through a mechanism involving hypoxia-inducible factor 1

  2009cited by this paper
• Altered regulation of metabolic pathways in human lung cancer discerned by 13C stable isotope-resolved metabolomics (SIRM)

  2009cited by this paper
• Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells.

  2009cited by this paper
• Intermittent hypoxia degrades HIF-2α via calpains resulting in oxidative stress: Implications for recurrent apnea-induced morbidities

  2009cited by this paper
• HIF-1α determines the metastatic potential of gastric cancer cells

  2009cited by this paper
• Tumor hypoxia and malignant progression.

  2009cited by this paper
• Suppression of hypoxia-inducible factor 2alpha restores p53 activity via Hdm2 and reverses chemoresistance of renal carcinoma cells.

  2009cited by this paper
• HIF2α inhibition promotes p53 pathway activity, tumor cell death, and radiation responses

  2009cited by this paper
• Oxygen regulates epithelial-to-mesenchymal transition: insights into molecular mechanisms and relevance to disease.

  2009cited by this paper
• Specific inhibition of hypoxia inducible factor 1 exaggerates cell injury induced by in vitro ischemia through deteriorating cellular redox environment

  2009cited by this paper
• Recent Advances in Cancer Therapy Targeting Proteins Involved in DNA Double-Strand Break Repair

  2009cited by this paper
• Targeted therapy for cancer using PARP inhibitors.

  2008cited by this paper
• Hypoxia and metabolism: Hypoxia, DNA repair and genetic instability

  2008cited by this paper
• K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

  2008cited by this paper
• High frequency of HIF-1α overexpression in BRCA1 related breast cancer

  2008cited by this paper
• PCAF is an HIF-1α cofactor that regulates p53 transcriptional activity in hypoxia

  2008cited by this paper
• HIF-alpha effects on c-Myc distinguish two subtypes of sporadic VHL-deficient clear cell renal carcinoma.

  2008cited by this paper
• The biology of cancer: metabolic reprogramming fuels cell growth and proliferation.

  2008cited by this paper
• Impaired DNA double-strand break repair contributes to chemoresistance in HIF-1 alpha-deficient mouse embryonic fibroblasts.

  2008cited by this paper
• PARP‐1 modulates deferoxamine‐induced HIF‐1α accumulation through the regulation of nitric oxide and oxidative stress

  2008cited by this paper
• Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response

  2008cited by this paper
• Hypoxia-associated markers in gastric carcinogenesis and HIF-2α in gastric and gastro-oesophageal cancer prognosis

  2008cited by this paper
• Evaluation of aspirin metabolites as inhibitors of hypoxia-inducible factor hydroxylases.

  2008cited by this paper
• Biology of HIF-1α

  2008cited by this paper
• High frequency of HIF-1alpha overexpression in BRCA1 related breast cancer.

  2008cited by this paper
• Poly(ADP-Ribose) Polymerase 1 Promotes Tumor Cell Survival by Coactivating Hypoxia-Inducible Factor-1–Dependent Gene Expression

  2008cited by this paper
• Disparate effects of simvastatin on angiogenesis during hypoxia and inflammation.

  2008cited by this paper
• Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response

  2008cited by this paper
• The biochemistry, metabolism and inherited defects of the pentose phosphate pathway: A review

  2008cited by this paper
• Target gene selectivity of hypoxia-inducible factor-α in renal cancer cells is conveyed by post-DNA-binding mechanisms

  2007cited by this paper
• The N-terminal transactivation domain confers target gene specificity of hypoxia-inducible factors HIF-1alpha and HIF-2alpha.

  2007cited by this paper
• Involvement of MGr1-Ag/37LRP in the vincristine-induced HIF-1 expression in gastric cancer cells

  2007cited by this paper
• Cellular senescence and cancer treatment.

  2007cited by this paper
• Regulation of hypoxia-inducible factors during inflammation.

  2007cited by this paper
• Hypoxia-inducible factor-1alpha is a key regulator of metastasis in a transgenic model of cancer initiation and progression.

  2007cited by this paper
• Hypoxia-Inducible Factor-1α Is a Key Regulator of Metastasis in a Transgenic Model of Cancer Initiation and Progression

  2007cited by this paper
• Hypoxia and Metastasis in Breast Cancer

  2007cited by this paper
• Hypoxia-induced genetic instability—a calculated mechanism underlying tumor progression

  2007cited by this paper
• The N-Terminal Transactivation Domain Confers Target Gene Specificity of Hypoxia-inducible Factors HIF-1α and HIF-2α

  2007cited by this paper
• Caffeine Inhibits Adenosine-Induced Accumulation of Hypoxia-Inducible Factor-1α, Vascular Endothelial Growth Factor, and Interleukin-8 Expression in Hypoxic Human Colon Cancer Cells

  2007cited by this paper
• Hypoxic regulation of telomerase gene expression by transcriptional and post-transcriptional mechanisms

  2006cited by this paper
• Inhibition of poly(ADP-ribose) polymerase modulates tumor-related gene expression, including hypoxia-inducible factor-1 activation, during skin carcinogenesis.

  2006cited by this paper
• BRCA1 Plays a Role in the Hypoxic Response by Regulating HIF-1α Stability and by Modulating Vascular Endothelial Growth Factor Expression*

  2006cited by this paper
• Metastasis‐associated protein 1 enhances stability of hypoxia‐inducible factor‐1α protein by recruiting histone deacetylase 1

  2006cited by this paper
• Heterozygous HIF‐1α deficiency impairs carotid body‐mediated systemic responses and reactive oxygen species generation in mice exposed to intermittent hypoxia

  2006cited by this paper
• Hypoxia-inducible factor-1α expression in the gastric carcinogenesis sequence and its prognostic role in gastric and gastro-oesophageal adenocarcinomas

  2006cited by this paper
• Recruitment of HIF-1alpha and HIF-2alpha to common target genes is differentially regulated in neuroblastoma: HIF-2alpha promotes an aggressive phenotype.

  2006cited by this paper
• Ca2+/Calmodulin Kinase-dependent Activation of Hypoxia Inducible Factor 1 Transcriptional Activity in Cells Subjected to Intermittent Hypoxia*

  2005cited by this paper
• HIF-2alpha expression in human fetal paraganglia and neuroblastoma: relation to sympathetic differentiation, glucose deficiency, and hypoxia.

  2005cited by this paper
• Two transactivation mechanisms cooperate for the bulk of HIF‐1‐responsive gene expression

  2005cited by this paper
• Epigallocatechin gallate inhibits HIF-1alpha degradation in prostate cancer cells.

  2005cited by this paper
• Epigallocatechin gallate inhibits HIF-1α degradation in prostate cancer cells

  2005cited by this paper
• Hypoxia inducible factor pathways as targets for functional foods.

  2005cited by this paper
• Resveratrol inhibits hypoxia-induced accumulation of hypoxia-inducible factor-1α and VEGF expression in human tongue squamous cell carcinoma and hepatoma cells

  2005cited by this paper
• HIF‐1α induces cell cycle arrest by functionally counteracting Myc

  2004cited by this paper
• n-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE2 induced ERK-1 and -2 and HIF-1alpha induction pathway.

  2004cited by this paper
• Hypoxia and Glucose Metabolism in Malignant Tumors: Evaluation by ( 18 F)Fluoromisonidazole and ( 18 F)Fluorodeoxyglucose Positron

  2004cited by this paper
• l-glutamine: a major substrate for tumor cells in vivo?

  2004cited by this paper
• HIF-1-mediated activation of telomerase in cervical cancer cells

  2004cited by this paper
• The AMP-activated protein kinase cascade--a unifying system for energy control.

  2004cited by this paper
• Hypoxia-Inducible Factor 1 Mediates Upregulation of Telomerase (hTERT)

  2004cited by this paper
• HIF-1alpha induces cell cycle arrest by functionally counteracting Myc.

  2004cited by this paper
• Hypoxia and Glucose Metabolism in Malignant Tumors

  2004cited by this paper

• Epigenetic Metal‐Organic Framework Nanoagonist Overcomes Triple Defenses to Enable Effective Chemo‐Metalloimmunotherapy in Platinum‐Resistant Ovarian Cancer

  2026cites this paper
• Temperature-Sensitive Nano-GOx Combined with Downregulation of Tumor Stemness to Initiate Robust Antitumor Efficacy.

  2025cites this paper
• Quantitative susceptibility mapping for the comprehensive assessment of adult-type diffuse gliomas.

  2025cites this paper
• Sono‐Responsive Hydrogel for Fractionated PROTAC Release to Alleviate Resistance and Immunosuppression Induced by Multi‐Course Postoperative Radiotherapy

  2025cites this paper
• Continuous-time random walk and fractional order calculus models histogram analysis of glioma biomarkers, including IDH1, ATRX, MGMT, and TERT, on differentiation

  2025cites this paper
• Multifunctional DNA nano-sponge system for targeted sensitization of ovarian cancer chemotherapy via metabolic reprogramming and ferroptosis induction.

  2025cites this paper
• Beyond conventional imaging: Advancements in MRI for glioma malignancy prediction and molecular profiling.

  2024cites this paper
• Imaging Genomics of Glioma Revisited: Analytic Methods to Understand Spatial and Temporal Heterogeneity

  2024cites this paper
• 2-Deoxy-D-glucose ameliorates inflammation and fibrosis in a silicosis mouse model by inhibiting hypoxia-inducible factor-1α in alveolar macrophages.

  2023cites this paper
• Regulation of phosphoglycerate kinase 1 and its critical role in cancer

  2023cites this paper
• MRI radiomics model for predicting TERT promoter mutation status in glioblastoma

  2023cites this paper
• Noninvasive prediction of IDH mutation status in gliomas using preoperative multiparametric MRI radiomics nomogram: A mutlicenter study.

  2023cites this paper
• Engineering micro oxygen factories to slow tumour progression via hyperoxic microenvironments

  2022cites this paper
• The basic functions of phosphoglycerate kinase 1 and its roles in cancer and other diseases.

  2022cites this paper
• Reciprocal Regulation of MAGED2 and HIF-1α Augments Their Expression under Hypoxia: Role of cAMP and PKA Type II

  2022cites this paper
• MAGED2 Is Required under Hypoxia for cAMP Signaling by Inhibiting MDM2-Dependent Endocytosis of G-Alpha-S

  2022cites this paper
• The role of hypoxia-inducible factor-1 alpha in multidrug-resistant breast cancer

  2022cites this paper
• Depletion of HIF-1α by Inducible Cre/loxP Increases the Sensitivity of Cultured Murine Hepatocytes to Ionizing Radiation in Hypoxia

  2022cites this paper
• Reactive oxygen species and DNA damage response in cancer.

  2021cites this paper
• Engineering Micro Oxygen Factory to Slow Tumor Progression by Hyperoxia Microenvironment

  2021cites this paper
• The prognostic outcome of ‘type 2 diabetes mellitus and breast cancer’ association pivots on hypoxia-hyperglycemia axis

  2021cites this paper
• A highly annotated database of genes associated with platinum resistance in cancer

  2021cites this paper
• Perfusion parameters derived from MRI for preoperative prediction of IDH mutation and MGMT promoter methylation status in glioblastomas.

  2021cites this paper
• Involvement of HIF-1α in the Detection, Signaling, and Repair of DNA Double-Strand Breaks after Photon and Carbon-Ion Irradiation

  2021cites this paper
• Circular RNA circ-MAT2B facilitates glycolysis and growth of gastric cancer through regulating the miR-515-5p/HIF-1α axis

  2020cites this paper
• Connexin 43 prevents the progression of diabetic renal tubulointerstitial fibrosis by regulating the SIRT1-HIF-1α signaling pathway.

  2020cites this paper
• PTBP3 contributes to colorectal cancer growth and metastasis via translational activation of HIF-1α

  2019cites this paper
• Glioma grading and IDH1 mutational status: assessment by intravoxel incoherent motion MRI.

  2019cites this paper
• MRI texture analysis based on 3D tumor measurement reflects the IDH1 mutations in gliomas - A preliminary study.

  2019cites this paper
• PGK1-mediated cancer progression and drug resistance.

  2019cites this paper
• Correlative analyses between tissue-based hypoxia biomarkers and hypoxia PET imaging in head and neck cancer patients during radiochemotherapy—results from a prospective trial

  2019cites this paper
• HIF‑1α promotes NLRP3 inflammasome activation in bleomycin‑induced acute lung injury.

  2019cites this paper
• Optimal control nodes in disease-perturbed networks as targets for combination therapy

  2019cites this paper
• VEGF-Grab Enhances the Efficacy of Radiation Therapy by Blocking VEGF-A and Treatment-Induced PlGF.

  2018cites this paper
• Disruption of Hif-1α enhances cytotoxic effects of metformin in murine squamous cell carcinoma

  2018cites this paper
• The Transcription Factor Hif-1 Enhances the Radio-Resistance of Mouse MSCs

  2018cites this paper
• Cellular density‐dependent increases in HIF‐1α compete with c‐Myc to down‐regulate human EP4 receptor promoter activity through Sp‐1‐binding region

  2018cites this paper
• Acetylation of PGK1 promotes liver cancer cell proliferation and tumorigenesis

  2017cites this paper
• Nuclear translocation of HIF-1α induced by influenza A (H1N1) infection is critical to the production of proinflammatory cytokines

  2017cites this paper
• HIF‐1α regulates EMT via the Snail and β‐catenin pathways in paraquat poisoning‐induced early pulmonary fibrosis

  2016cites this paper
• The radioresistance of mesenchymal stromal cells and their potential role in the management of radiation injury

  2016cites this paper
• AMPK and HIF signaling pathways regulate both longevity and cancer growth: the good news and the bad news about survival mechanisms

  2016cites this paper
• [Inherited primitive and secondary polycythemia].

  2016cites this paper
• Leptin contributes to long-term stabilization of HIF-1α in cancer cells subjected to oxygen limiting conditions.

  2016cites this paper
• Tissue and imaging biomarkers for hypoxia predict poor outcome in endometrial cancer

  2016cites this paper
• Targeted Therapy in Hematological Malignancies: From Basic Research to Clinical Practice

  2015cites this paper
• Annexin A1 sustains tumor metabolism and cellular proliferation upon stable loss of HIF1A

  2015cites this paper
• Identification of biomarkers for development of NF1-associated malignant peripheral nerve sheath tumours

  2015cites this paper
• Cell metabolism under microenvironmental low oxygen tension levels in stemness, proliferation and pluripotency.

  2015cites this paper
• Targeted Therapies in Adult B-Cell Malignancies

  2015cites this paper
• X609, a novel manassantin A derivative, exhibits antitumor activity in MG-63 human osteosarcoma cells in vitro and in vivo.

  2015cites this paper
• STAT3 and HIF1α Signaling Drives Oncogenic Cellular Phenotypes in Malignant Peripheral Nerve Sheath Tumors

  2015cites this paper
• The In Vitro and In Vivo Activity of the Microtubule Disruptor STX140 Is Mediated by Hif-1 Alpha and CAIX Expression.

  2015cites this paper
• Inhibition of vascular endothelial growth factor A and hypoxia-inducible factor 1α maximizes the effects of radiation in sarcoma mouse models through destruction of tumor vasculature.

  2015cites this paper
• IDH mutation status is associated with a distinct hypoxia/angiogenesis transcriptome signature which is non-invasively predictable with rCBV imaging in human glioma

  2015cites this paper
• Influence of different hypoxia models on metastatic potential of SGC-7901 gastric cancer cells

  2014cites this paper
• Hypoxia in prostate cancer: Gene expression profiling in relation to disease aggressiveness and treatment interventions

  2014influential citation
• Chronodisruption increases cardiovascular risk in zebrafish via reduced clearance of senescent erythrocytes

  2014cites this paper
• MicroRNAs as regulators of mitochondrial function: role in cancer suppression.

  2014cites this paper
• MicroRNA regulation of cancer metabolism: role in tumour suppression.

  2014cites this paper
• Cellular changes, molecular pathways and the immune system following photodynamic treatment.

  2014cites this paper
• A Synthetic Manassantin A Derivative Inhibits Hypoxia-Inducible Factor 1 and Tumor Growth

  2014cites this paper
• Cellular density-dependent down-regulation of EP4 prostanoid receptors via the up-regulation of hypoxia-inducible factor-1α in HCA-7 human colon cancer cells

  2014cites this paper
• The return of metabolism: biochemistry and physiology of the pentose phosphate pathway

  2014cites this paper
• Peritoneal Milky Spots Serve as a Hypoxic Niche and Favor Gastric Cancer Stem/Progenitor Cell Peritoneal Dissemination Through Hypoxia-Inducible Factor 1α

  2014cites this paper
• Targeting DNA damage response in cancer therapy

  2014cites this paper
• EAF2 Suppresses Hypoxia-Induced Factor 1α Transcriptional Activity by Disrupting Its Interaction with Coactivator CBP/p300

  2014cites this paper
• Hypoxia Enhances the Radioresistance of Mouse Mesenchymal Stromal Cells

  2014cites this paper
• HIF1α Modulates Cell Fate Reprogramming Through Early Glycolytic Shift and Upregulation of PDK1–3 and PKM2

  2014cites this paper
• Hypoxia reduces and redirects selenoprotein biosynthesis.

  2014cites this paper
• HIF 1 { alpha } modulates reprogramming through early glycolytic shift and up-regulation of PDK 1-3 and PKM 2

  2014cites this paper
• Probing hypoxia-induced staurosporine resistance in prostate cancer cells with a microfluidic culture system.

  2014cites this paper
• Beclin-1-independent autophagy positively regulates internal ribosomal entry site-dependent translation of hypoxia-inducible factor 1α under nutrient deprivation

  2014cites this paper
• The response of mouse mesenchymal stromal cells to radiation-induced DNA double-strand breaks

  2013cites this paper
• Application of two‐dimensional gel‐based mass spectrometry to functionally dissect resistance to targeted cancer therapy

  2013cites this paper
• Tumor cell heterogeneity.

  2013cites this paper
• Tumor heterogeneity, clonal evolution, and therapy resistance: an opportunity for multitargeting therapy.

  2013influential citation
• X 609 , a novel manassantin A derivative , exhibits antitumor activity in MG-63 human osteosarcoma cells in vitro and in vivo

  year unknowncites this paper